IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics

Reuters

12/01

IonQ and CCRM Launch <a href="https://laohu8.com/S/QMCO">Quantum</a>-Biotech Partnership for Advanced <a href="https://laohu8.com/S/LENZ">Therapeutics</a>

IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IONQ Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2588278847"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588278847\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588278847?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 20:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588278847","market":"us","top_or_hot":-1,"title":"IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IonQ and CCRM Launch <a href=\"https://laohu8.com/S/QMCO\">Quantum</a>-Biotech Partnership for Advanced <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/IONQ\">IONQ Inc.</a> published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-12-01 20:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      IonQ and CCRM Launch <a href=\"https://laohu8.com/S/QMCO\">Quantum</a>-Biotech Partnership for Advanced <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/IONQ\">IONQ Inc.</a> published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IONQ","symbol_name":"IONQ Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL8CSCLZ:1","article_id":"2588278847","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588278847","pubTimestamp":1764592244,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine  to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IONQ":"IONQ Inc.","BK4170":"电脑硬件、储存设备及电脑周边","BK4591":"室温超导概念","BK4602":"量子计算概念"},"translate_title":"IonQ和CCRM建立量子生物技术合作伙伴关系以开发先进疗法","themeId":"9d2740edf4f0b98ff0520696a67e8073","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IONQ":0.9},"content_text":"IonQ and CCRM Launch Quantum-Biotech Partnership for Advanced Therapeutics\n\n\n        IonQ Inc., a leading quantum technology company, has announced a strategic partnership with the Centre for Commercialization of Regenerative Medicine (CCRM) to accelerate the development of advanced therapeutics using hybrid quantum and quantum-AI technologies. As the core technology partner across CCRM's global regenerative medicine network, IonQ will support quantum-biotech initiatives focused on bioprocess optimization, disease-modeling workflows, and quantum-enhanced simulation for advanced therapy design and manufacturing. The collaboration includes an investment commitment from IonQ and will launch initial projects in Canada and Sweden in 2026, aiming to revolutionize therapeutic development, biomanufacturing, and healthcare delivery.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IONQ Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251201706303) on December 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}